Literature DB >> 17389506

Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1.

Yanli Zhu1, Yunhong Zhang, Beryl A Ojwang, Milam A Brantley, Jeffrey M Gidday.   

Abstract

PURPOSE: To determine whether the duration of ischemic tolerance in the retina could be extended by repetitive presentations of the preconditioning stimulus and to begin to elucidate the mechanistic underpinnings of the resultant novel phenotype.
METHODS: Adult male Swiss-Webster ND4 mice were repeatedly preconditioned with systemic hypoxia (RHP) over 12 days; 4 weeks later, the mice were subjected to 30 minutes of unilateral retinal ischemia. Protection was quantified morphologically and functionally 1 week after ischemia by histologic analyses and scotopic electroretinography, respectively. Temporal expression patterns of hypoxia-inducible factor (HIF)-1alpha and heme oxygenase (HO)-1 were measured in response to RHP and after retinal ischemia by immunoblot analysis and immunohistochemistry.
RESULTS: Morphologic and functional protection against ischemia-induced reductions in retinal layer thicknesses and layer cell counts, and a- and b-wave amplitudes, was documented for at least 4 weeks after RHP. There was no evidence of tissue injury or dysfunction by RHP alone. Temporally associated with this period of long-term tolerance (LTT) to retinal ischemia were sustained increases in retinal levels of HIF-1alpha and HO-1 protein lasting at least 1 and 4 weeks, respectively, after the last RHP stimulus.
CONCLUSIONS: A novel form of sustained retinal ischemic tolerance is described, wherein endogenous adaptive responses triggered by repeated hypoxia afford protection against injury many weeks after the preconditioning stimulus. HIF-1alpha-mediated, long-lasting increases in retinal HO-1 expression may contribute to the LTT phenotype. Further elucidation of the genetic and molecular basis of such adaptive plasticity could provide therapeutic targets for preventing and/or treating a variety of ischemic retinopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389506     DOI: 10.1167/iovs.06-1037

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.

Authors:  John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  Exp Eye Res       Date:  2010-11-20       Impact factor: 3.467

Review 2.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

Review 3.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

4.  Adaptive Plasticity in the Retina: Protection Against Acute Injury and Neurodegenerative Disease by Conditioning Stimuli.

Authors:  Jeffrey M Gidday
Journal:  Cond Med       Date:  2018-02-15

5.  Ionic dysregulatory phenotyping of pathologic retinal thinning with manganese-enhanced MRI.

Authors:  Bruce A Berkowitz; Marius Gradianu; Stephen Schafer; Ying Jin; Andre Porchia; Raymond Iezzi; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-24       Impact factor: 4.799

6.  Quantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in mice.

Authors:  Katherine Poinsatte; Uma Maheswari Selvaraj; Sterling B Ortega; Erik J Plautz; Xiangmei Kong; Jeffrey M Gidday; Ann M Stowe
Journal:  J Vis Exp       Date:  2015-05-04       Impact factor: 1.355

7.  Lrg participates in lipopolysaccharide preconditioning-induced brain ischemia injury via TLR4 signaling pathway.

Authors:  Gu Gong; Shurong Bai; Wei Wu; Ling Hu; Yinghai Liu; Jie Niu; Xuemei Dai; Liang Yin; Xiaowu Wang
Journal:  J Mol Neurosci       Date:  2014-02-15       Impact factor: 3.444

8.  Active HIF-1 in the normal human retina.

Authors:  John M Hughes; Arjan J Groot; Petra van der Groep; René Sersansie; Marc Vooijs; Paul J van Diest; Cornelis J F Van Noorden; Reinier O Schlingemann; Ingeborg Klaassen
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

9.  HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia.

Authors:  Freya M Mowat; Ulrich F O Luhmann; Alexander J Smith; Clemens Lange; Yanai Duran; Sarah Harten; Deepa Shukla; Patrick H Maxwell; Robin R Ali; James W B Bainbridge
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

10.  Aqueous humor hepcidin prohormone levels in patients with primary open angle glaucoma.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Alireza Javadzadeh; Behzad Fallahi Motlagh; Solmaz Shoa Ahari
Journal:  Mol Vis       Date:  2010-09-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.